Why are US stocks near record highs again?
How will Walmart's price hikes affect consumers?
What caused Moody's to downgrade US credit rating?
Why is Trump attacking Walmart over tariffs?
How will Charter's buyout of Cox impact cable industry?
What are implications of NJ Transit rail strike?
Why did MIT disavow AI productivity paper?
How are AI and robotics stocks poised to perform?
What effect does Trump’s Middle East trip have on trade?
Acadia Pharmaceuticals price target raised to $19 from $17 at Oppenheimer
finance.yahoo.com/news/acadia-pharmaceuticals-price-target-raised-173632511.html
In This Article:
Oppenheimer raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $19 from $17 and keeps a Perform rating on the shares. The firm sees the Delaware court’s verdict in favor of Acadia as consistent with its expectations for Nuplazid intellectual property…
This story appeared on finance.yahoo.com, 2025-05-17 17:36:32.